WSC
AGN

White Square Capital’s Allergan plc AGN Stock Holding History

White Square Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-189,410
Closed -$33.5M – 23
2020
Q1 		$33.5M Buy
189,410
+118,607
+168% +$22.3M 14.35% 3
2019
Q4 		$13.5M Buy
70,803
+7,233
+11% +$1.3M 9.79% 4
2019
Q3 		$10.7M Buy
+63,570
New +$10.4M 8.9% 4

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

White Square Capital's AGN Position: Q2 2020 in Review

White Square Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 189,410 shares — an estimated $33.5M sold.

White Square Capital first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $33.5M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • White Square Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • White Square Capital sold 189,410 Allergan plc shares in Q2 2020, an estimated $33.5M.
  • White Square Capital first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • White Square Capital's Allergan plc position peaked at $33.5M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on White Square Capital's 13F filing for Q2 2020, filed 13 Aug 2020.